CAMERON BAKER

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement.

Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism.

Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives, specifically H.R.6835. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. Take Care of American Veterans Act: Specifically advocating for modernizing the VA's prosthetics and implant procurement program by increasing resources, expanding clinical and procurement expertise, and requiring implementation of a nationwide electronic ordering system.

Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives, specifically H.R.6835. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. Take Care of American Veterans Act: Specifically advocating for modernizing the VA's prosthetics and implant procurement program by increasing resources, expanding clinical and procurement expertise, and requiring implementation of a nationwide electronic ordering system.

Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives, specifically H.R.6835. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. Take Care of American Veterans Act: Specifically advocating for modernizing the VA's prosthetics and implant procurement program by increasing resources, expanding clinical and procurement expertise, and requiring implementation of a nationwide electronic ordering system.

Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives, specifically H.R.6835. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. Take Care of American Veterans Act: Specifically advocating for modernizing the VA's prosthetics and implant procurement program by increasing resources, expanding clinical and procurement expertise, and requiring implementation of a nationwide electronic ordering system.

Issues related to the U.S. House discussion draft of the Great American AI Act (GAAIA) - Advocacy and education efforts on the importance of FDA retaining regulatory authority over AI used in medical devices, and on redundant or potentially harmful regulations that could impair patient access to devices or hinder innovation. Issues related to SECURE Data Act (H.R. 8413) - Advocacy for the inclusion of healthcare-related carveouts with exemptions for HIPAA covered entities and business associates, health records, and certain clinical research and patient-safety data. Also, advocacy for the inclusion of language preempting state frameworks by establishing a single federal standard.

Issues related to the U.S. House discussion draft of the Great American AI Act (GAAIA) - Advocacy and education efforts on the importance of FDA retaining regulatory authority over AI used in medical devices, and on redundant or potentially harmful regulations that could impair patient access to devices or hinder innovation. Issues related to SECURE Data Act (H.R. 8413) - Advocacy for the inclusion of healthcare-related carveouts with exemptions for HIPAA covered entities and business associates, health records, and certain clinical research and patient-safety data. Also, advocacy for the inclusion of language preempting state frameworks by establishing a single federal standard. Issues related to the Health Care Cybersecurity and Resiliency Act of 2026 (S.3315) - Advocacy related to the inclusion of language excluding medical device manufacturers from S. 3315 SEC. 8. Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015.

Issues related to FY2027 National Defense Authorization Act (NDAA) (S. 4784 & H.R. 8800) - Advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Reform of Technical Data and Software Rights to Support Competition, Sustainment, and Readiness (section 861 of H.R. 8800), the Modifications to Technical Data Rights (section 804 of S. 4784), and other provisions related to healthcare and proprietary data.

Issues related to the issuance of dividends and stock buybacks, including provisions of H.R. 8800/S.4784, the National Defense Authorization Act of 2027.

Issues related to FY2027 National Defense Authorization Act (NDAA) (S. 4784 & H.R. 8800) - Advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Reform of Technical Data and Software Rights to Support Competition, Sustainment, and Readiness (section 861 of H.R. 8800), the Modifications to Technical Data Rights (section 804 of S. 4784), and other provisions related to healthcare and proprietary data.

Ensuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. The Advancing Research for Chronic Pain Act (S. 5041), directs the CDC to regularly collect, analyze, and report data on the prevalence, burden, and impact of chronic pain in the US and build a centralized Chronic Pain Information Hub. The Relief of Chronic Pain Act (S. 3064), which would lower cost-sharing and bar step therapy and prior authorization for non-opioid treatments under Medicare Part D. Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) (Public Law 109-417) - advocacy on risk mitigation plans and voluntary shortage reporting related to medical device supply chains and advocacy for medical research and to foster a new era of medical innovation and prepare for future pandemics and promote health equity. Support passage of the Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 - Senate (S. 1031) & (H.R. 2120). This legislation would increase access to patient care, enhance the quality of cancer treatments, encourage innovation, reduce disparities for rural and underserved patients, and lower patient costs by saving Medicare about $200 million over 10 years. The WISeR Model (Wasteful and Inappropriate Service Reduction Model) - Advocacy efforts on inclusions in CMS' WISeR model, which is aimed at reducing inappropriate care and preventing improper payments under Medicare Part B by refining prior authorization processes for traditional fee-for-service Medicare. Engaged on the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway and efforts to streamline FDA-CMS coordination and Medicare coverage for Breakthrough Devices.

Ensuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. The Advancing Research for Chronic Pain Act (S. 5041), directs the CDC to regularly collect, analyze, and report data on the prevalence, burden, and impact of chronic pain in the US and build a centralized Chronic Pain Information Hub. The Relief of Chronic Pain Act (S. 3064), which would lower cost-sharing and bar step therapy and prior authorization for non-opioid treatments under Medicare Part D. Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) (Public Law 109-417) - advocacy on risk mitigation plans and voluntary shortage reporting related to medical device supply chains and advocacy for medical research and to foster a new era of medical innovation and prepare for future pandemics and promote health equity. Support passage of the Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 - Senate (S. 1031) & (H.R. 2120). This legislation would increase access to patient care, enhance the quality of cancer treatments, encourage innovation, reduce disparities for rural and underserved patients, and lower patient costs by saving Medicare about $200 million over 10 years. The WISeR Model (Wasteful and Inappropriate Service Reduction Model) - Advocacy efforts on inclusions in CMS' WISeR model, which is aimed at reducing inappropriate care and preventing improper payments under Medicare Part B by refining prior authorization processes for traditional fee-for-service Medicare. Engaged on the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway and efforts to streamline FDA-CMS coordination and Medicare coverage for Breakthrough Devices.

Issues related to the U.S. House discussion draft of the Great American AI Act (GAAIA) - Advocacy and education efforts on the importance of FDA retaining regulatory authority over AI used in medical devices, and on redundant or potentially harmful regulations that could impair patient access to devices or hinder innovation. Issues related to SECURE Data Act (H.R. 8413) - Advocacy for the inclusion of healthcare-related carveouts with exemptions for HIPAA covered entities and business associates, health records, and certain clinical research and patient-safety data. Also, advocacy for the inclusion of language preempting state frameworks by establishing a single federal standard. Issues related to the Health Care Cybersecurity and Resiliency Act of 2026 (S.3315) - Advocacy related to the inclusion of language excluding medical device manufacturers from S. 3315 SEC. 8. Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015.

Issues related to FY2027 National Defense Authorization Act (NDAA) (S. 4784 & H.R. 8800) - Advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Reform of Technical Data and Software Rights to Support Competition, Sustainment, and Readiness (section 861 of H.R. 8800), the Modifications to Technical Data Rights (section 804 of S. 4784), and other provisions related to healthcare and proprietary data.

Issues related to FY2027 National Defense Authorization Act (NDAA) (S. 4784 & H.R. 8800) - Advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Reform of Technical Data and Software Rights to Support Competition, Sustainment, and Readiness (section 861 of H.R. 8800), the Modifications to Technical Data Rights (section 804 of S. 4784), and other provisions related to healthcare and proprietary data.

Issues related to the issuance of dividends and stock buybacks, including provisions of H.R. 8800/S.4784, the National Defense Authorization Act of 2027.

Ensuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. The Advancing Research for Chronic Pain Act (S. 5041), directs the CDC to regularly collect, analyze, and report data on the prevalence, burden, and impact of chronic pain in the US and build a centralized Chronic Pain Information Hub. The Relief of Chronic Pain Act (S. 3064), which would lower cost-sharing and bar step therapy and prior authorization for non-opioid treatments under Medicare Part D. Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) (Public Law 109-417) - advocacy on risk mitigation plans and voluntary shortage reporting related to medical device supply chains and advocacy for medical research and to foster a new era of medical innovation and prepare for future pandemics and promote health equity. Support passage of the Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 - Senate (S. 1031) & (H.R. 2120). This legislation would increase access to patient care, enhance the quality of cancer treatments, encourage innovation, reduce disparities for rural and underserved patients, and lower patient costs by saving Medicare about $200 million over 10 years. The WISeR Model (Wasteful and Inappropriate Service Reduction Model) - Advocacy efforts on inclusions in CMS' WISeR model, which is aimed at reducing inappropriate care and preventing improper payments under Medicare Part B by refining prior authorization processes for traditional fee-for-service Medicare. Engaged on the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway and efforts to streamline FDA-CMS coordination and Medicare coverage for Breakthrough Devices.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025. H.R. 1 (and Senate Amendment 2360) The One Big Beautiful Bill Act- Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, the Section 250 deduction, Roundtripping, Section 899, and to return to pre-2022 R&D expensing rules.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025. To restore immediate tax deductions for research and development (R&D) expenses, reversing the requirement that companies amortize these costs over several years. H.R. 1 (and Senate Amendment 2360) The One Big Beautiful Bill Act- Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, the Section 250 deduction, Roundtripping, Section 899, and to return to pre-2022 R&D expensing rules.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025 - advocacy for legislation to return to pre-2022 R&D expensing rules. TCJA Reauthorization - Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, and the Section 250 deduction.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025. H.R. 1 (and Senate Amendment 2360) The One Big Beautiful Bill Act- Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, the Section 250 deduction, Roundtripping, Section 899, and to return to pre-2022 R&D expensing rules.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025. To restore immediate tax deductions for research and development (R&D) expenses, reversing the requirement that companies amortize these costs over several years. H.R. 1 (and Senate Amendment 2360) The One Big Beautiful Bill Act- Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, the Section 250 deduction, Roundtripping, Section 899, and to return to pre-2022 R&D expensing rules.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025 - advocacy for legislation to return to pre-2022 R&D expensing rules. TCJA Reauthorization - Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, and the Section 250 deduction.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025. H.R. 1 (and Senate Amendment 2360) The One Big Beautiful Bill Act- Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, the Section 250 deduction, Roundtripping, Section 899, and to return to pre-2022 R&D expensing rules.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025. To restore immediate tax deductions for research and development (R&D) expenses, reversing the requirement that companies amortize these costs over several years. H.R. 1 (and Senate Amendment 2360) The One Big Beautiful Bill Act- Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, the Section 250 deduction, Roundtripping, Section 899, and to return to pre-2022 R&D expensing rules.

Issues related to FY2026 National Defense Authorization Act (NDAA) (Public Law No. 119-60, S.1071, S.2296, & H.R.3838) - advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Requirement for Contractors to Provide Reasonable Access to Repair Materials (section 863 of H.R. 3838) and other provisions related to healthcare.

FY2026 National Defense Authorization Act (NDAA) (H.R. 3838/S.2296) - Section 863 of H.R. 3838: Requirement for Contractors to Provide Reasonable Access to Repair Materials If enacted this legislation would enforce an expansive right to repair (RTR) policy on any businesses that contract with the Department of War, mandating that manufacturers provide access to proprietary data and tools. We are engaging in advocacy efforts to have the provision in the House bill removed from the final legislation, and educating lawmakers on the critical role of the Food and Drug Administration in maintaining product safety and effectiveness throughout the device lifecycle in addition to the potential risks associated with third-party servicing of medical technologies.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025 - advocacy for legislation to return to pre-2022 R&D expensing rules. TCJA Reauthorization - Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, and the Section 250 deduction.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025. To restore immediate tax deductions for research and development (R&D) expenses, reversing the requirement that companies amortize these costs over several years. H.R. 1 (and Senate Amendment 2360) The One Big Beautiful Bill Act- Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, the Section 250 deduction, Roundtripping, Section 899, and to return to pre-2022 R&D expensing rules.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation. H.R. 1990 American Innovation and R&D Competitiveness Act of 2025. H.R. 1 (and Senate Amendment 2360) The One Big Beautiful Bill Act- Maintaining the International Tax regime as established in the 2017 TCJA legislation. Policies include proposed changes to GILTI, specifically Country by Country Reporting, the Section 250 deduction, Roundtripping, Section 899, and to return to pre-2022 R&D expensing rules.

OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement.

Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans.

Issues related to FY2026 National Defense Authorization Act (NDAA) (Public Law No. 119-60, S.1071, S.2296, & H.R.3838) - advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Requirement for Contractors to Provide Reasonable Access to Repair Materials (section 863 of H.R. 3838) and other provisions related to healthcare.

FY2026 National Defense Authorization Act (NDAA) (H.R. 3838/S.2296) - Section 863 of H.R. 3838: Requirement for Contractors to Provide Reasonable Access to Repair Materials If enacted this legislation would enforce an expansive right to repair (RTR) policy on any businesses that contract with the Department of War, mandating that manufacturers provide access to proprietary data and tools. We are engaging in advocacy efforts to have the provision in the House bill removed from the final legislation, and educating lawmakers on the critical role of the Food and Drug Administration in maintaining product safety and effectiveness throughout the device lifecycle in addition to the potential risks associated with third-party servicing of medical technologies.

Issues related to FY2026 National Defense Authorization Act (NDAA) (Public Law No. 119-60, S.1071, S.2296, & H.R.3838) - advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Requirement for Contractors to Provide Reasonable Access to Repair Materials (section 863 of H.R. 3838) and other provisions related to healthcare.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Final Rule (RIN 3084-AB74) - FTC rulemaking preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's final rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Final Rule (RIN 3084-AB74) - FTC rulemaking preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's final rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Final Rule (RIN 3084-AB74) - FTC rulemaking preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's final rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation. American Privacy Rights Act of 2024 (H.R. 8818) - advocacy for inclusion of an exemption for biomedical research that is compliant with an existing regulatory framework for human subjects research to avoid unintended conflicts and burdens; advocacy for inclusion of an exemption for information maintained by an entity that meets the definition of Health Care Provider under HIPAA to prevent unintended negative impacts on patient care, and avoid unnecessary lawsuits for uses and disclosures of patient data that are enabled under HIPAA and critical to a functioning healthcare system.

Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation. American Privacy Rights Act of 2024 (H.R. 8818) - advocacy for inclusion of an exemption for biomedical research that is compliant with an existing regulatory framework for human subjects research to avoid unintended conflicts and burdens; advocacy for inclusion of an exemption for information maintained by an entity that meets the definition of Health Care Provider under HIPAA to prevent unintended negative impacts on patient care, and avoid unnecessary lawsuits for uses and disclosures of patient data that are enabled under HIPAA and critical to a functioning healthcare system.

Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation. American Privacy Rights Act of 2024 (H.R. 8818) - advocacy for inclusion of an exemption for biomedical research that is compliant with an existing regulatory framework for human subjects research to avoid unintended conflicts and burdens; advocacy for inclusion of an exemption for information maintained by an entity that meets the definition of Health Care Provider under HIPAA to prevent unintended negative impacts on patient care, and avoid unnecessary lawsuits for uses and disclosures of patient data that are enabled under HIPAA and critical to a functioning healthcare system.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Final Rule (RIN 3084-AB74) - FTC rulemaking preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's final rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Final Rule (RIN 3084-AB74) - FTC rulemaking preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's final rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Final Rule (RIN 3084-AB74) - FTC rulemaking preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's final rule.

Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation. American Privacy Rights Act of 2024 (H.R. 8818) - advocacy for inclusion of an exemption for biomedical research that is compliant with an existing regulatory framework for human subjects research to avoid unintended conflicts and burdens; advocacy for inclusion of an exemption for information maintained by an entity that meets the definition of Health Care Provider under HIPAA to prevent unintended negative impacts on patient care, and avoid unnecessary lawsuits for uses and disclosures of patient data that are enabled under HIPAA and critical to a functioning healthcare system.

Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation. American Privacy Rights Act of 2024 (H.R. 8818) - advocacy for inclusion of an exemption for biomedical research that is compliant with an existing regulatory framework for human subjects research to avoid unintended conflicts and burdens; advocacy for inclusion of an exemption for information maintained by an entity that meets the definition of Health Care Provider under HIPAA to prevent unintended negative impacts on patient care, and avoid unnecessary lawsuits for uses and disclosures of patient data that are enabled under HIPAA and critical to a functioning healthcare system.

Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation. American Privacy Rights Act of 2024 (H.R. 8818) - advocacy for inclusion of an exemption for biomedical research that is compliant with an existing regulatory framework for human subjects research to avoid unintended conflicts and burdens; advocacy for inclusion of an exemption for information maintained by an entity that meets the definition of Health Care Provider under HIPAA to prevent unintended negative impacts on patient care, and avoid unnecessary lawsuits for uses and disclosures of patient data that are enabled under HIPAA and critical to a functioning healthcare system.

Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation.

Senate Armed Services Committee's National Defense Authorization Act for Fiscal Year 2025 (S.4638) "Right to Repair" Provision (Sec. 828) - If enacted this legislation would would force an expansive "right to repair (RTR)" on any businesses that contract with the Department of Defense. We are engaging in advocacy efforts towards the removal of this provision from the final bill, educating lawmakers on the critical role of the Food and Drug Administration in maintaining product safety and effectiveness throughout the device lifecycle, and the potential risks associated with third-party servicing of medical technologies.

Senate Armed Services Committee's National Defense Authorization Act for Fiscal Year 2025 (S.4638) "Right to Repair" Provision (Sec. 828) - If enacted this legislation would would force an expansive "right to repair (RTR)" on any businesses that contract with the Department of Defense. We are engaging in advocacy efforts towards the removal of this provision from the final bill, educating lawmakers on the critical role of the Food and Drug Administration in maintaining product safety and effectiveness throughout the device lifecycle, and the potential risks associated with third-party servicing of medical technologies.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation. H.R.7024 - Tax Relief for American Families and Workers Act of 2024: Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

The Workforce Mobility Act of 2023 (S. 220/ H.R. 731) - prohibits the use of non-compete agreements in the context of commercial enterprises except under certain circumstances. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from proposed non-competes ban. FTC Non-Compete Clause Proposed Rulemaking (Matter Number P201200) - proposed rule preventing employers from entering into non-compete clauses with workers and requiring employers to rescind existing non-compete clauses. Advocacy to exclude select leaders and employees with access to intellectual property and trade secrets from FTC's proposed rule.

Sen. Schumer's "SAFE" Innovative Framework and Sens. Thune and Klobuchar's AI Research, Innovation and Accountability Act of 2023 (S.3312) - advocacy and education efforts to ensure that FDA retains regulatory authority over artificial intelligence used in medical devices to avoid any harmful regulations that could impair patient access to devices or hinder innovation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.

American Innovation and R&D Competitiveness Act of 2023 (H.R. 2673), Build It in America Act (H.R. 3938), & American Innovation and Jobs Act (S.866): Research and Development (R&D) Expensing - advocacy for legislation to return to pre-2022 R&D expensing rules. OECD 2 Pillar Framework Implementation- International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs and Investment Act (H.R. 3665) legislation regarding extraterritorial taxation.